Surjit Bhimarao Dixit
Plus aucun poste en cours
Profil
Surjit Bhimarao Dixit worked as Vice President-Technology at Zymeworks BC, Inc. Prior to that, he worked as Coordinator-Computational Molecular Biophysics at Wesleyan University from 2005 to 2007 and as Research Associate at Henri Poincaré University from 1999 to 2001.
Dixit holds a doctorate degree from Indian Institute of Technology New Delhi.
Anciens postes connus de Surjit Bhimarao Dixit
| Sociétés | Poste | Fin |
|---|---|---|
| Wesleyan University | Corporate Officer/Principal | 01/07/2007 |
| Henri Poincaré University | Corporate Officer/Principal | 01/02/2001 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | - |
Formation de Surjit Bhimarao Dixit
| Indian Institute of Technology New Delhi | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
